Drinking Risk Level Reductions Associated with Improvements in Physical Health and Quality of Life among Individuals with Alcohol Use Disorder

BACKGROUND. Abstinence and no heavy drinking days are currently the only Food and Drug Administration (FDA) approved endpoints in clinical trials for alcohol use disorder (AUD). Many individuals who fail to meet these criteria may substantially reduce their drinking during treatment and most individ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alcohol Clin Exp Res
Hauptverfasser: Witkiewitz, Katie, Kranzler, Henry R., Hallgren, Kevin A., O’Malley, Stephanie S., Falk, Daniel E., Litten, Raye Z., Hasin, Deborah S., Mann, Karl F., Anton, Raymond F.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2018
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6286196/
https://ncbi.nlm.nih.gov/pubmed/30395350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/acer.13897
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge